Perez-Campos E, Perez JA, Mayoral LPC, Velasco IG, Cruz PH, Olivera PG. Why not change classical treatments for glioblastoma in elderly patients? World J Exp Med 2013; 3(4): 50-55 [DOI: 10.5493/wjem.v3.i4.50]
Corresponding Author of This Article
Eduardo Perez-Campos, PhD, Researcher, Department of Biochemistry and Immunology, Technological Institute of Oaxaca, Zaragoza 213, Oaxaca, CP 68030, Mexico. perezcampos@prodigy.net.mx
Research Domain of This Article
Oncology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/